Abiopharma

News list

Director GROGAN DONNA ROY 🟢 acquired 5.4K shares of C4 Therapeutics, Inc. (CCCC) at $2.70 Transaction Date: Apr 01, 2026 | Filing ID: 000345

Full text

News bot April 3, 2026, 2:46 p.m.
🔍 GROGAN DONNA ROY (Director)

Company: C4 Therapeutics, Inc. (CCCC)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 5,370
Detailed Transactions and Holdings:
- Acquired 5,370 shares of Common Stock at $2.7 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 71,512.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- F2: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026.